Paper32243786
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.
Wang D and 2 others. Cell, 2020. Cited by 420 papers, by iCite.
Cite this record
ConductScience Library. CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors. Papers, record 32243786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32243786
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CRISPR-Cas Systems | Major topic |
| Dependovirus | Major topic |
| Gene Editing | Major topic |
| Genetic Therapy | Major topic |
| Genetic Vectors | Major topic |
| Animals | |
| Humans |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UG3 HL147367 | NHLBI NIH HHS | United States | UG3HL147367 | PubMed and NIH | NIH RePORTER |
| P01 HL131471 | NHLBI NIH HHS | United States | P01HL131471 | PubMed and NIH | NIH RePORTER |
| DP1 HL141201 | NHLBI NIH HHS | United States | DP1HL141201 | PubMed and NIH | NIH RePORTER |
| R01 NS076991 | NINDS NIH HHS | United States | R01NS076991 | PubMed and NIH | NIH RePORTER |
| R01 HG009761 | NHGRI NIH HHS | United States | R01HG009761 | PubMed and NIH | NIH RePORTER |
| RM1 HG006193 | NHGRI NIH HHS | United States | RM1HG006193 | PubMed and NIH | NIH RePORTER |
| R01 HL097088 | NHLBI NIH HHS | United States | R01HL097088 | PubMed and NIH | NIH RePORTER |
| R01 MH110049 | NIMH NIH HHS | United States | R01MH110049 | PubMed and NIH | NIH RePORTER |
| Howard Hughes Medical Institute | United States | PubMed | PubMed |
References165
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31740768 | Adenine base editing in an adult mouse model of tyrosinaemia. | Nat Biomed Eng | 2020 | https://conductscience.org/library/papers/31740768 | PubMed |
| 2 | 28956530 | Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. | Elife | 2017 | https://conductscience.org/library/papers/28956530 | PubMed |
| 3 | 24916110 | Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing. | Circ Res | 2014 | https://conductscience.org/library/papers/24916110 | PubMed |
| 4 | 30664785 | Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. | Nat Med | 2019 | https://conductscience.org/library/papers/30664785 | PubMed |
| 5 | 23892898 | CRISPR RNA-guided activation of endogenous human genes. | Nat Methods | 2013 | https://conductscience.org/library/papers/23892898 | PubMed |
| 6 | 30778238 | Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. | Nat Med | 2019 | https://conductscience.org/library/papers/30778238 | PubMed |
| 7 | 31000663 | Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq. | Science | 2019 | https://conductscience.org/library/papers/31000663 | PubMed |
| 8 | 30944467 | Precise therapeutic gene correction by a simple nuclease-induced double-stranded break. | Nature | 2019 | https://conductscience.org/library/papers/30944467 | PubMed |
| 9 | 29872041 | In vivo base editing of post-mitotic sensory cells. | Nat Commun | 2018 | https://conductscience.org/library/papers/29872041 | PubMed |
| 10 | 23503052 | Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. | Nat Methods | 2013 | https://conductscience.org/library/papers/23503052 | PubMed |
| 11 | 30670702 | Engineering of CRISPR-Cas12b for human genome editing. | Nat Commun | 2019 | https://conductscience.org/library/papers/30670702 | PubMed |
| 12 | 31759123 | Rational designs of in vivo CRISPR-Cas delivery systems. | Adv Drug Deliv Rev | 2021 | https://conductscience.org/library/papers/31759123 | PubMed |
| 13 | 29326962 | Emerging Issues in AAV-Mediated In Vivo Gene Therapy. | Mol Ther Methods Clin Dev | 2018 | https://conductscience.org/library/papers/29326962 | PubMed |
| 14 | 26735016 | High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. | Nature | 2016 | https://conductscience.org/library/papers/26735016 | PubMed |
| 15 | 30742127 | Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/30742127 | PubMed |
| 16 | 25830891 | In vivo genome editing using Staphylococcus aureus Cas9. | Nature | 2015 | https://conductscience.org/library/papers/25830891 | PubMed |
| 17 | 26643939 | Cell cycle reactivation of cochlear progenitor cells in neonatal FUCCI mice by a GSK3 small molecule inhibitor. | Sci Rep | 2015 | https://conductscience.org/library/papers/26643939 | PubMed |
| 18 | 25096198 | Nature's recipe for splitting inteins. | Protein Eng Des Sel | 2014 | https://conductscience.org/library/papers/25096198 | PubMed |
| 19 | 28751571 | In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28751571 | PubMed |
| 20 | 30158648 | Cas9 immunity creates challenges for CRISPR gene editing therapies. | Nat Commun | 2018 | https://conductscience.org/library/papers/30158648 | PubMed |
Cited by317
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 420 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42903334 | Engrailed-1 in eccrine sweat gland development and regeneration: from evolutionary innovation to therapeutic perspectives. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42903334 | PubMed |
| 42890117 | CasNano: An ultracompact CRISPR-Cas12f with a GC-rich PAM for epigenome editing with therapeutic potential. | Mol Ther Nucleic Acids | 2026 | https://conductscience.org/library/papers/42890117 | PubMed |
| 42811129 | Controllable gene delivery via masked adeno-associated viral vectors. | Nat Mater | 2026 | https://conductscience.org/library/papers/42811129 | PubMed |
| 42805175 | Non-invasive control of gene editing in vivo by photoswitchable Cas12f and focused ultrasound. | Cell | 2026 | https://conductscience.org/library/papers/42805175 | PubMed |
| 42787623 | Clinical translation of CRISPR-Cas9 therapeutics in cancer and inherited genetic disorders. | Front Genome Ed | 2026 | https://conductscience.org/library/papers/42787623 | PubMed |
| 42753721 | De novo-engineered guide RNA-directed transposition with TnpB-family proteins. | Mol Cell | 2026 | https://conductscience.org/library/papers/42753721 | PubMed |
| 42749924 | Structure-guided discovery and engineering of miniature CRISPR-Cas12m for epigenome editing. | Nat Struct Mol Biol | 2026 | https://conductscience.org/library/papers/42749924 | PubMed |
| 42676584 | Engineered MSC-exosomes as CRISPR-Cas9 delivery vectors for precision immunotherapy. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42676584 | PubMed |
| 42595755 | Genome-wide CRISPR screening identifies cellular factors controlling nonviral genome editing efficiency. | Nat Commun | 2026 | https://conductscience.org/library/papers/42595755 | PubMed |
| 42524609 | In vivo delivery strategies for therapeutic CRISPR genome editing. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42524609 | PubMed |
| 42465491 | Programmable CRISPRtune dissects the transcriptional repressive activity of MeCP2. | bioRxiv | 2026 | https://conductscience.org/library/papers/42465491 | PubMed |
| 42444979 | Delivery Systems for Therapeutic Genome Editing: Challenges, Innovations, and Future Perspectives. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42444979 | PubMed |
| 42432197 | Efficient in vivo cytosine base editing using virus-like particles with uracil DNA glycosylase inhibition. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42432197 | PubMed |
| 42410265 | CD4-directed nanoblades enable selective genome editing in CD4+ cells and HIV suppression in vitro and in vivo. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42410265 | PubMed |
| 42334650 | Immune-smart nanocarriers for nucleic acid oncology: engineering biomaterials for safe, precise, and durable responses. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42334650 | PubMed |
| 42307737 | [Cell and gene therapies in Menière's disease: perspectives for a slowly progressive inner ear disease]. | HNO | 2026 | https://conductscience.org/library/papers/42307737 | PubMed |
| 42298891 | Inducible CRISPR/Cas systems in precision oncology: Current applications and future perspectives. | Clin Transl Med | 2026 | https://conductscience.org/library/papers/42298891 | PubMed |
| 42297566 | Encapsulin-Protected Immunotherapeutic Complexes: Bacteria-Derived Nanoparticles for mRNA Delivery to Eukaryotic Cells. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42297566 | PubMed |
| 42247138 | CRISPR/Cas‑based epigenome editing for osteogenic lineage commitment. | Cell Tissue Res | 2026 | https://conductscience.org/library/papers/42247138 | PubMed |
| 42162502 | From mechanism to medicine: CRISPR‒Cas9 delivery strategies, therapeutic applications and translation challenges. | Discov Nano | 2026 | https://conductscience.org/library/papers/42162502 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32243786
GET https://conductscience.org/api/papers/v1/32243786/references?page=2